CDTX — Cidara Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapNeutral

Annual balance sheet for Cidara Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	35.9	59.7	32.7	35.8	190
Net Total Accounts Receivable
Net Total Receivables	11.2	5.36	5.83	16.2	1.69
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	57.2	71.7	45.1	60.9	211
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.21	2.54	1.32	5.13	3.96
Other Long Term Assets
Total Assets	60.4	75.3	47.5	67	215
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	38.6	34	41.4	67.4	49.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	49.7	53.8	61.9	75.2	51.5
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	10.7	21.6	-14.4	-8.21	163
Total Liabilities & Shareholders' Equity	60.4	75.3	47.5	67	215
Total Common Shares Outstanding